M

MGI Tech Stack

Clinical-grade gene sequencers and multi-omics platforms for precision medicine

Biotechnology Research Shenzhen, Guangdong 1,001–5,000 employees Founded 2016 Public Company

MGI manufactures gene sequencers and genomics instruments across a range of throughput capacities (Gb to Tb), alongside reagents and automation platforms for life-science labs. The company is sales-heavy in hiring, with 9 of 20 active roles in sales across emerging markets (Brazil, Russia, Middle East, Asia), while simultaneously scaling bioinformatics and customer-facing operations—a pattern consistent with geographic expansion and shifting product adoption from internal R&D to commercial deployment.

Tech Stack 11 technologies

Core StackPython AWS Microsoft Office Oracle ERP Concur Word Excel Adobe Acrobat R Seurat Bash

What MGI Is Building

◆Challenges

Expanding operations in brazil
Slow adoption of mgi solutions
Expanding presence in russia/cis
Complex payroll processes across multiple agencies
Compliance with local employment laws
Maintaining accurate financials
Improving internal controls
Contract accounting management
Grow oncology revenue
Regulatory compliance in russia and cis region

▲Active Projects

Financial processes and it system improvements
Month-end closing and reporting
Adoption of mgi genomics platform in me
Adoption of automation platform in me
Adoption of bio bank solution in me
Tax compliance and annual audit support
Deploy and support bioinformatics software and pipelines
Oem regulatory pathway project
Develop pipelines for single-cell and spatial genomics data
Transition workflows from r&d to customer-facing teams

Hiring Activity

Accelerating20 roles · 10 in 30d

Department

Sales

9

Support

3

Engineering

2

Finance

2

Data

1

HR

1

Legal

1

Research

1

Seniority

Senior

9

Mid

7

Manager

4

Company intelligence

Find more companies like MGI by tech stack, pain points and active projects

Get started free

About MGI

MGI Tech designs and manufactures genetic sequencers, laboratory automation systems, and reagent kits for research institutions, hospitals, and diagnostics labs worldwide. Founded in 2016 and headquartered in Shenzhen, the company has established facilities across six continents. The product portfolio spans clinical-grade sequencing instruments at varying capacities, multi-omics platforms, bioinformatics pipelines, and biobank solutions. Current priorities include expanding market penetration in Brazil and Russia, deploying bioinformatics software to customer-facing teams, and scaling adoption of internal genomics and automation platforms across regional operating entities.

HeadquartersShenzhen, Guangdong

Company Size1,001–5,000 employees

Founded2016

Hiring MarketsSaudi Arabia, Spain, Russia, Turkey, Brazil, United Arab Emirates, United States, Canada

Frequently Asked Questions

What sequencing platforms does MGI manufacture?

MGI produces clinical-grade gene sequencers with throughput capacities ranging from Gb to Tb levels, alongside multi-omics instruments and automation platforms for genomics workflows.

Where is MGI hiring internationally?

MGI has active recruitment across 10+ countries: Saudi Arabia, Spain, Russia, Turkey, Brazil, UAE, US, Canada, India, and Singapore. Sales roles dominate the pipeline (9 of 20 active positions).

What is MGI working on operationally?

Key projects include geographic expansion in Brazil and Russia, adoption of automation and biobank solutions across regional entities, bioinformatics pipeline deployment, and OEM regulatory compliance.